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ABSTRACT
Background
The Kassena-Nankana District of northern Ghana lies in the African ‘‘meningitis belt’’ where
epidemics of meningococcal meningitis have been reoccurring every eight to 12 years for the
last 100 years. The dynamics of meningococcal colonisation and disease are incompletely
understood, and hence we embarked on a long-term study to determine how levels of
colonisation with different bacterial serogroups change over time, and how the patterns of
disease relate to such changes.
Methods and Findings
Between February 1998 and November 2005, pharyngeal carriage of Neisseria meningitidis in
the Kassena-Nankana District was studied by twice-yearly colonisation surveys. Meningococcal
disease was monitored throughout the eight-year study period, and patient isolates were
compared to the colonisation isolates. The overall meningococcal colonisation rate of the study
population was 6.0%. All culture-confirmed patient isolates and the majority of carriage isolates
were associated with three sequential waves of colonisation with encapsulated (A ST5, X ST751,
and A ST7) meningococci. Compared to industrialised countries, the colonising meningococcal
population was less constant in genotype composition over time and was genetically less
diverse during the peaks of the colonisation waves, and a smaller proportion of the isolates was
nonserogroupable. We observed a broad age range in the healthy carriers, resembling that of
meningitis patients during large disease epidemics.
Conclusions
The observed lack of a temporally stable and genetically diverse resident pharyngeal flora of
meningococci might contribute to the susceptibility to meningococcal disease epidemics of
residents in the African meningitis belt. Because capsular conjugate vaccines are known to
impact meningococcal carriage, effects on herd immunity and potential serogroup replace-
ment should be monitored following the introduction of such vaccines.
The Editors’ Summary of this article follows the references.
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The highest burden of meningococcal meningitis occurs in
the ‘‘meningitis belt’’ of sub-Saharan Africa, a region
stretching from Senegal to Ethiopia with an estimated
population of 300 million [1,2]. Within individual areas of
the meningitis belt, major disease epidemics occur in
irregular cycles every eight to 12 years, with attack rates
ranging from 100 to 1,000 per 100,000 population [3].
Epidemics start in the early dry season, stop abruptly at the
onset of the rains, but may break out again in the following
dry season. Low humidity and high temperatures may favour
the occurrence of meningococcal disease by damaging
mucosal surfaces and the immune defence. In any one
country, epidemics occur over a period of only two to three
years [1]. The periodicity of these epidemics is not well
understood, nor is it possible to predict them accurately. The
current approach for control of meningococcal disease
epidemics is based on early detection of the disease by the
epidemic threshold of ten to 15 cases per 100,000 inhabitants
per week [4] followed by mass immunisations with poly-
saccharide vaccines [3]. However, in settings with limited
resources, effective surveillance and timely interventions are
difﬁcult to implement, and therefore vaccination campaigns
are often delayed [1].
N. meningitidis can be classiﬁed into 13 serogroups on the
basis of the chemical composition of its polysaccharide
capsule [5]. Serogroup A accounts for most epidemics in
the African meningitis belt, but C and W135 epidemics have
also been reported [1,6]. Meningococci that cause epidemics
are genetically closely related; speciﬁc genotypes plus their
epidemiologically associated genetic descendants constitute
‘‘genoclouds’’ [7]. The two most recent meningococcal disease
pandemics originated in Asia and were caused by serogroup
A meningococci belonging to two related genoclouds [7].
These two genoclouds have been assigned the sequence type
(ST) 5 and ST7, respectively, based on multilocus sequence
typing [7,8]. At the time we started our study serogroup W135
meningococci was considered a rare cause of invasive disease.
However, two recent W135 meningitis outbreaks in Mecca
were followed by major epidemics in Burkina Faso [6,9].
N. meningitidis is a commensal of the human nasopharyngeal
mucosa. It is transmitted by aerosol droplets or through
contact with respiratory secretions. Because meningococcal
transmission is independent of disease, characterisation of
the carrier state is crucial for understanding the epidemiol-
ogy of meningococcal disease. Multiple colonisation studies
have been performed in industrialised countries, but little is
known about the meningococcal colonisation dynamics in
Africa. Here, we report the ﬁndings of the ﬁrst (to our
knowledge) long-term colonisation study carried out in the
African meningitis belt.
Methods
Study Area
The study was conducted in the Kassena-Nankana District
(KND) of the Upper-East Region of Ghana. It lies within the
Guinea savannah woodland and has two major seasons: a
short wet season from June to October and a long dry season
for the rest of the year. The district population is about
140,000, mainly rural, except for the 20,000 inhabitants of
Navrongo town. In the KND, people live in compounds with
an average of ten inhabitants [10]. Between 1997 and 2002,
yearly vaccination campaigns with meningococcal serogroup
A/C polysaccharide vaccine targeted the whole district
population. Between 2003 and 2005, smaller campaigns were
carried out. In 2003, 80% of the study participants were
reported to have been vaccinated within the previous three
years.
Table 1. Carriage Rates in Percentage during 16 Carriage Surveys in the KND
Survey Date Samples N. lactamica,
Percentage
(SE)
N. Meningitidis
Percentage
(SE)
Serogroup A,
Percentage
(SE)
Serogroup X
Percentage
(SE)
1 April 1998 300 9.3 (2.7) 4.7 (1.6) 2.7 (1.1)
2 November 1998 299 8.7 (2.2) 3.0 (1.3) 1.0 (0.6)
3 April 1999 292 8.2 (1.8) 5.1 (1.5) 0.7 (0.5) 3.4 (1.4)
4 November 1999 308 9.7 (2.0) 4.2 (1.7) 0.3 (0.3) 1.9 (1.1)
5 April 2000 298 8.4 (2.4) 19.8 (3.7) 17.4 (4.0)
6 November 2000 301 6.0 (2.4) 13.6 (6.0) 11.0 (4.3)
7 April 2001 310 8.4 (2.2) 17.1 (2.9) 15.8 (2.6)
8 November 2001 306 6.5 (2.2) 2.0 (0.8) 1.3 (0.6)
9 April 2002 339 4.7 (1.4) 2.7 (1.0) 1.2 (0.7) 0.6 (0.4)
10 November 2002 319 5.6 (1.5) 2.8 (1.3) 1.9 (1.2) 0.6 (0.4)
11 April 2003 312 5.4 (1.6) 2.9 (1.1) 2.2 (1.1)
12 November 2003 297 6.4 (2.1) 3.4 (1.2) 1.3 (0.8) 1.0 (0.6)
13 April 04 350 3.7 (1.3) 8.0 (2.2) 4.3 (1.5)
14 November 2004 313 1.9 (0.8) 5.8 (1.9) 0.6 (0.5)
15 April 2005 321 0.3 (0.3) 3.1 (1.0) 0.9 (0.5)
16 November 2005 334 0.6 (0.4) 0.6 (0.4)
aFor NG strains the PFGE patterns are given, if more than one NG strain was isolated, the number of carriers are added in parentheses. A, X, Y is the typical pattern of the respective
serogroups. PFGE-pattern is not known. 192 is the NG ST192-pattern.
bD and its 95% CIs were determined according to Grundmann et al. [18] on the basis of serogroup diversity.
NT, nontypable (PFGE pattern is not known); SE, standard error of the percentage calculated with allowance for cluster sampling.
doi:10.1371/journal.pmed.0040101.t001
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Clonal Waves of N. meningitidisEthical Approval and Consent
Ethical clearance for this study was obtained from the
relevant institutional review boards and the Ghana Ministry
of Health. Informed consent was obtained from all study
participants.
Colonisation Isolates
We randomly selected 37 residential compounds from a
complete listing of the district population using the
Navrongo Demographic Surveillance System (NDSS) [11].
The sample size was chosen to include a total population of
about 300 individuals per survey, which means that a carriage
rate of 5% at any one survey (corresponding to relatively
frequent infection) can be distinguished at a signiﬁcance level
of 5% from those of infrequent infections carried by only
2.5% of the population.
Throat swabs were taken twice annually from all inhab-
itants of the 37 compounds present at the time of the visit
who agreed to participate. A total of 16 surveys have been
performed since March 1998; in each of them between 292
and 350 study participants have been swabbed (Table 1). The
number of participants swabbed in single compounds ranged
from zero to 30 (mean 8.57, median 6); ﬂuctuations in these
numbers were due to travelling activities. Three individuals
refused to participate in the study; as a result one of the
compounds was discontinued after the ﬁrst visit. Another
compound was replaced in April 2002 after being deserted by
its inhabitants. The age distribution of the study participants
was comparable with the overall age distribution in the KND
(Table 2).
At the compound visit, each throat swab was taken and
directly inoculated on Thayer-Martin agar plates [12]. From
each positive plate, two colonies with neisserial morphology
were subcultured. N. meningitidis and N. lactamica colonies
were identiﬁed by standard bacteriological methods as
previously described [12].
Disease Isolates
Patients with suspected meningitis presenting at the War
Memorial Hospital, Navrongo, or one of the four health
centres of the KND were recruited throughout the study
period. Suspected meningitis was deﬁned by sudden onset of
fever and stiff neck in the patient, or fever and stiff neck and
altered mental status, in accordance with World Health
Organization guidelines [3]. A lumbar puncture was per-
formed before treatment on all patients with suspected
meningitis, and the cerebrospinal ﬂuid specimen was
analysed in the laboratory of the War Memorial Hospital as
described previously [12]. In 1998–1999, only samples
collected during the dry season were analysed. Thereafter,
samples collected from the few patients with suspected
meningitis who presented during the wet season were also
included.
Characterisation of Bacterial Isolates
Meningococci were serogrouped with serogroup-speciﬁc
antisera (Difco, http://www.bd.com) according to the manu-
facturer’s instruction. In a subset of isolates, serological
typing was conﬁrmed by PCR [13,14]. All isolates were
analysed by pulsed-ﬁeld gel electrophoresis (PFGE) after
digestion of genomic DNA with NheI [15]. Multilocus
sequence typing was performed as described [8].
Statistical Methods
As a measure of the invasiveness of the different
genoclouds, we computed the ratio of cases to the approx-
imate number of carriers in the district (Table 3). To estimate
the latter we assumed that each survey was representative of
the six-month period in which it was carried out, and that
average duration of carriage is six months, corresponding
approximately to the half-life of N. meningitidis carriage
determined in a study in university students in the United
Kingdom [16]. The diversity index (D) (Table 1) of the
meningococcal carriage population was determined with
respect to the serogroup distribution for each of the 16
surveys and for the overall study period using the Simpson
index [17,18].
The unadjusted proportion of samples carrying each
bacterium provides a consistent and unbiased estimate of
carriage prevalence; however, because of the random
Table 1. Continued
Survey Serogroup Y
Percentage
(SE)
Serogroup W135
Percentage
(SE)
Serogroup 29E
Percentage
(SE)
Serogroup B
Percentage
(SE)
Nongroupable
Percentage
(SE)
PFGE
Pattern of
NG Strains
a
Simpson’s Index
of Diversity
D (95% CI)
b
1 1.3 (1.3) 0.3 (0.3) 0.3 (0.3) A 0.374 (0.173–0.575)
2 0.7 (0.7) 0.3 (0.3) 1.0 (0.5) A, X, NT 0.194 (0.092–0.296)
3 0.7 (0.7) 0.3 (0.3) NT 0.448 (0.181–0.715)
4 0.6 (0.4) 1.3 (0.7) X, NT (3) 0.282 (0.134–0.43)
5 1.3 (0.9) 1.0 (0.7) X, Y, NT 0.78 (0.642–0.918)
6 2.7 (1.9) X (7), Y 0.678 (0.527–0.829)
7 1.3 (0.7) X, Y (3) 0.855 (0.729–0.981)
8 0.3 (0.3) 0.3 (0.3) X 0.4 (0.015–0.785)
9 0.9 (0.7) 0.278 (0.162–0.394)
10 0.3 (0.3) 0.444 (0.139–0.749)
11 0.3 (0.3) 0.3 (0.3) 0.583 (0.243–0.953)
12 0.3 (0.3) 0.7 (0.5) 192, X 0.222 (0.096–0.349)
13 0.3 (0.3) 0.9 (0.8) 0.3 (0.3) 0.3(0.3) 2.0 (0.7) 192 (5), A (2) 0.341 (0.194–0.488)
14 0.6 (0.6) 4.2 (1.9) 192 (12), Y, NT 0.608 (0.347–0.869)
15 2.2 (0.7) 192 (5), NT (2) 0.533 (0.301–0.765)
16 0.6 (0.4) NT (2) 1.0 (0)
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procedure introduced extrabinomial variation, which was
allowed for in the estimates of standard errors (Table 1) by
calculating robust (sandwich) estimates [19] using Stata
version 8.0 (Stata Corporation, http://www.stata.com).
Risk ratios and conﬁdence intervals (CIs) were calculated
using EpiInfo version 3.3.2 (http://www.cdc.gov/EpiInfo), but
these analyses treated the different samples as statistically
independent, and consequently some of the tests carried out
are anticonservative because of the effects of repeated
sampling of the same individuals. We draw attention to the
implications of this repeat sampling where applicable.
Results
Clonal Waves of Meningococcal Colonisation and Disease
We monitored the dynamics of pharyngeal carriage of N.
meningitidis and bacterial meningitis in the KND of northern
Ghana from February 1998 to November 2005; three major
waves of clonal colonisation and disease with encapsulated
meningococci were observed. A meningitis epidemic oc-
curred in the dry season of 1996–1997 with 1,396 suspected
meningitis cases in the KND, but because of lack of
infrastructure no laboratory analysis was performed [20].
This epidemic was followed by a smaller outbreak with 50
laboratory-conﬁrmed serogroup A meningitis cases in the
following dry season. A total of 36 isolates were culture
conﬁrmed and identiﬁed as subgroup III, ST5 bacteria [12],
which spread throughout the meningitis belt after an
epidemic in Mecca in 1987 [21]. Carriage of serogroup A
ST5 meningococci decreased steadily from 2.7% (8/301) in
April 1998 to 0.3% (1/308) in November 1999 (Figure 1A).
Thereafter, none of the clinical or colonisation isolates from
the KND belonged to the serogroup A ST5 genocloud. In
2000, no serogroup A meningococci were isolated from either
patients or carriers. However, in 2001, a new wave of
Table 2. Age Distribution of the Overall Study Population during Eight-Year Colonisation Surveys in Comparison with the Overall
Population in the KND According to Navrongo Demographic Surveillance System Surveys 1995–1999
Age Study Population Swabbed Total Population of the KND
a
Male Percentage of the
Total Population
Female Percentage of the
Total Population
Male Percentage of the
Total Population
Female Percentage of the
Total Population
,5 319 6.43 340 6.85 9,780 7.07 9,721 7.03
5–10 322 6.49 501 10.10 10,329 7.47 9,932 7.18
10–15 375 7.56 344 6.93 10,007 7.23 9,077 6.56
15–20 266 5.36 294 5.93 7,585 5.48 6,520 4.71
20–30 253 5.10 346 6.97 7,587 5.48 9,325 6.74
30–40 164 3.31 328 6.61 5,935 4.29 9,114 6.59
40–50 246 4.96 211 4.25 4,928 3.56 7,443 5.38
.50 302 6.09 351 7.07 9,092 6.57 11,960 8.65
Total 2,247 45.28 2,715 54.72 65,243 47.16 73,092 52.84
aMean denominator of the population between 1995 and 1999.
doi:10.1371/journal.pmed.0040101.t002
Table 3. Ratio of Meningitis Cases Versus 1,000 Carriers for Serogroup A and X at Different Time Points
Period Serogroup A Serogroup X
Carrier (n) Cases (n) Ratio
a (95% CI) Carrier (n) Cases (n) Ratio (95% CI)
January–June 1998 8 43 11.7 (5.4–28.7) 1 ‘
July–December 1998 3
January–June 1999 2 10 1 0.2 (0–1.5)
July–December 1999 1 6
January–June 2000 52 7 0.3 (0.1–0.6)
July–December 2000 33
January–June 2001 49 3 0.1 (0–0.4)
July–December 2001 7 ‘ 4
January–June 2002 4 2 1 1.2 (0–23.5)
July–December 2002 6 69 42.3 (15.8–159.5) 2
January–June 2003 7 1 0.4 (0–3.2) 1 ‘
July–December 2003 4 52 16.8 (7.6–43.7) 3 1 0.7 (0–8.9)
January–June 2004 15 2 1.1 (0.1–7.5)
July–December 2004 2 111 18.7 (10.9–34.6)
January–June 2005 3 2 1.5 (0.1–13.5)
July–December 2005
aThe total population of the KND was estimated at 138,335 (http://www.indepth-network.net/dss_site_profiles/navrongo.pdf).
CI, confidence interval.
doi:10.1371/journal.pmed.0040101.t003
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All serogroup A carrier and disease strains isolated since then
belonged to a new genocloud of serogroup A meningococci
associated with ST7 that was observed for the ﬁrst time in
Africa in 1995 [7]. Although colonisation was still low in April
2001 (i.e., ,0.3%), seven serogroup A ST7 meningitis cases
were identiﬁed between February and March 2001. In the
following three years, serogroup A ST7 colonisation rates of
1.2%–4.3% were observed. Despite yearly serogroup A/C
polysaccharide mass immunisations, this low level of colo-
nisation was associated with repeated serogroup A ST7
meningitis outbreaks in the KND (Figure 1A). Laboratory-
conﬁrmed cases numbered 70 between January and May 2002,
56 were identiﬁed between January and May 2003, and 113
were identiﬁed between December 2003 and April 2004.
Thereafter, the serogroup A ST7 colonisation rate dropped
below 1%, and only two serogroup A ST7 meningitis cases
were recorded in February 2005.
Between the two waves of serogroup A colonisation and
disease, we documented a wave of colonisation with a
serogroup X ST751 genocloud (Figure 1B) [22,23]. The
extensive spread of this low-virulence serogroup was asso-
ciated with a total of 15 meningitis cases between 1998 and
2003. Serogroup X carriage and disease peaked in the dry
seasons of 1999/2000 and 2000/2001, with colonisation rates
of 17.3% and 15.1%, respectively. While in the peak of the
serogroup X wave the ratio of serogroup X cases to carriers
was found to be between 0.1 and 0.3:1,000 (Table 3), and the
observed ratio of serogroup A cases versus carriers during the
A ST7 outbreak was between 16.8 and 42.3:1,000 in the
respective dry seasons.
Since November 2003, 23 non(sero)groupable (NG) ST192
carriage isolates with closely related PFGE patterns were
collected (Figure 1B). Their colonisation rate peaked in
November 2004 at 3.8% (12/313). NG ST192 strains isolates
have been previously reported from The Gambia and Niger
(for listing, see http://pubmlst.org/perl/mlstdbnet/mlstdbnet.
pl?page¼st-query&ﬁle¼pub-nm_isolates.xml).
Investigation of Patients with Meningitis
Throughout the study period, 1,145 suspected meningitis
patients were recruited and cerebrospinal ﬂuid samples were
analysed in the lab. Overall, 311 meningococcal meningitis
cases were conﬁrmed by culture and/or latex agglutination.
Furthermore, a pneumococcal meningitis outbreak with
serotype 1 dominating occurred between 2000 and 2003
[24], while overall only 17 Haemophilus inﬂuenzae meningitis
cases were reported. We obtained meningococcal isolates in
197/311 (63%) of conﬁrmed cases.
Latex agglutination conﬁrmed the serogroup A capsule for
all 114 cerebrospinal ﬂuid samples that were negative in
culture. All recovered disease isolates belonged to the three
dominating genoclouds of encapsulated meningococci (36
serogroup A ST5, 148 serogroup A ST7, and 15 serogroup X
strains). With respect to colonisation, 289 (5.8%) of the
pharyngeal samples contained N. lactamica and 302 (6.0%) N.
meningitidis. Point prevalence of the different serogroups at
the 16 individual surveys is given in Table 1. All serogroup A
(n ¼ 55) and serogroup X (n ¼ 161) carriage isolates belonged
to the three genoclouds causing the major sequential
colonisation waves. In addition, 16 NG isolates shared ST
and PFGE patterns with the isolates of serogroup A ST5 (two
isolates), serogroup A ST7 (two isolates), or serogroup X (12
isolates), respectively (Figure 1A). These colonisation isolates
thus represented unencapsulated variants of the respective
genoclouds. There was no evidence for an accumulation of
the nonencapsulated variants toward the end of the colo-
nisation waves (Figure 1). In some cases, encapsulated and NG
variants of the same genocloud were found simultaneously in
the same compound. Bacterial carriage showed only moder-
ate clustering by compound. Of the 39 compounds sampled
at least once, 31 (79%) provided at least one N. lactamica and
36 (92%) at least one N. meningitidis positive sample. Of the
583 individual compound visits, 158 (27%) yielded N. lactamica
and 155 (27%) N. meningitidis.
To compare these numbers with those expected if the
bacteria were randomly distributed between compounds, we
selected 289 of the samples in the database at random and
found that 208 different visits including 38 compounds were
represented, while a different, independent set of 302
samples chosen at random corresponded to 213 visits to 37
of the compounds.
The diversity index D (Table 1) varied strongly between the
single-sampling time points. Highly homogenous carriage
populations were found in the course of colonisation waves
with peak values of D ¼ 0.855 in April 2001 for the X wave,
and D ¼ 0.583 in April 2003 for the A ST7 wave. In contrast,
carriage isolates were much more diverse in the transition
phase between two clonal waves with the lowest values of D¼
0.194 in November 1998 during the transition from A ST5 to
X, and D ¼ 0.278 in April 2002 during the transition from X
to A ST7. Overall, the serogroup diversity in the KND (D ¼
0.349, 95% CI 0.306–0.393) was slightly lower than in a
carriage study in Europe (D¼0.282, 95% CI 0.251–0.313) [25].
Low Background of Meningococci Unrelated to the Clonal
Waves
Only from 16.6% (50/302) of the meningococcal carriers
were colonisation isolates unrelated to the dominating
serogroup A, X, and NG ST192 genoclouds (Figure 1C).
Although neighbouring Burkina Faso was hit by repeated
W135 ST11 epidemics in the dry seasons of 2002–2004, in the
KND carriers of the epidemic strain were only found in April
2004 (3/350; 0.9%) and November 2004 (2/313; 0.6%), and not
a single W135 meningitis case was recorded between 1998 and
2005 [26]. Single carriers of W135 ST11 meningococci were
also identiﬁed in April (1/300) and in November 1998 (1/299)
[23], two years prior to a ﬁrst documented W135 meningitis
outbreak in Mecca [9]. While serogroup Y meningococci (21
isolates) and serogroup Y ST168 related NG strains (seven
isolates) were isolated in ten out of the 16 individual surveys,
carriage of serogroup B and serogroup 29E meningococci was
rare (Table 1). Carriage of serogroup Y meningococci was
strongly associated with one particular compound, where
during eight of the 16 surveys, 67% (14/21) of the serogroup Y
strains were isolated. Altogether, only eight NG isolates had
PFGE patterns and STs unrelated to the dominating
serogroup A, X, Y, and NG ST192 genoclouds (Table 1).
While the N. lactamica carriage rate remained relatively
constant (4.7%–9.3%) for six years, it declined after April
2004 to 0.3% in April 2005 (Figure 1D). We observed no
signiﬁcant association between the A/C meningococcal
polysaccharide vaccine immunisation status and meningo-
coccal carriage of all serogroups (relative risk [RR]¼1.11; p¼
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Clonal Waves of N. meningitidisFigure 1. Waves of Colonisation and Disease in the KND from April 1998 until November 2005
Carriage rates recorded during 16 colonisation surveys (April and November each year) and monthly numbers of confirmed meningitis cases of N.
meningitidis.
(A) Genoclouds of serogroup A ST5 and ST7 meningococci are shown.
(B) Genoclouds of serogoup X ST851 and NG ST192 meningococci are shown.
(C) Carriage rates of other serogroups and meningococci unrelated to the A, X, or NG ST192 genoclouds are shown.
(D) Carriage rates of N. lactamica are shown.
doi:10.1371/journal.pmed.0040101.g001
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Clonal Waves of N. meningitidis0.81; 95% CI 0.65–1.95), of serogroup A (RR ¼ 0.9; p ¼ 0.92;
95% CI 0.42–1.88), or of N. lactamica (in the .2-year-old RR¼
0.7; p¼0.3; 95% CI 0.37–1.27). These CIs do not allow for the
effect of clustering in the sampling. An analysis that allowed
for clustering would give even higher p-values, conﬁrming the
absence of effect.
Age Distribution of Carriers and Patients
Colonisation with meningococci in the KND exhibited a
broad age range (Figure 2A). It peaked in teenagers and
young adults (median age 17.9 y; range 5 mo–84 y). In
contrast, the carriage rate of N. lactamica was highest in the
,5-y age group (Figure 2B). During the 1996/1997 epidemic
the age pattern of clinically diagnosed meningitis patients
(median age 17.8 y; range 3 mo–80 y) resembled that of
meningococcal carriers (Figure 2C), the incidence rates (IRs)
of males (n ¼ 628; IR ¼ 9.5 per 1,000 population) and females
(n¼713; 9.8 per 1,000) were comparable (RR¼0.97; p¼0.59).
In contrast, during the postepidemic serogroup A meningo-
coccal disease outbreaks between 1998 and 2005, the
incidence of meningitis was highest in children ,10 y of
age and decreased steadily with age (Figure 2C). The median
age of A ST5 cases in 1998 and of A ST7 cases in 2001–2005
was comparable (8.0 y; range 4 mo–64 y versus 10.0 y; range 2
mo–75 y, respectively). However, between 2001 and 2005 the
IR of males (n ¼ 159; IR ¼ 0.49 per 1,000) was signiﬁcantly
higher (RR¼2.0; p , 0.001) than of females (n¼89; IR¼0.24
per 1,000). The case fatality rate of A meningococcal
meningitis was much higher during the A ST5 postepidemic
outbreak in 1998 (20%; 10/50) than during the epidemic in
1996–1997 (4.7%; 65/1396; p , 0.001) or during the A ST7
outbreaks in 2001–2005 (4.8%; 11/238; p , 0.001).
Discussion
Here, we present the results of the ﬁrst longitudinal study
(to our knowledge) on meningococcal colonisation and
disease in the meningitis belt of sub-Saharan Africa. The
study revealed features that are in many aspects remarkably
different from ﬁndings of colonisation studies conducted in
Europe and North America [5,27–30]. The population of
meningococci carried in the KND (i) was less constant in
genotype composition; (ii) was less genetically diverse during
the peaks of colonisation waves; (iii) included fewer NG
strains; and (iv) was characterised by dominant virulent
encapsulated strains. Indeed, the A ST5, A ST7, and X ST751
meningococci responsible for all 197 culture-reconﬁrmed
meningitis cases represented 71% (216/302) of the colonisa-
tion isolates.
These results allow us to describe the major developments
in meningococcal carriage and disease in the KND over an
eight-year study period that included both meningococcal
outbreaks and the interepidemic periods. We recorded very
good compliance of the study participants. However, ﬁnan-
cial and organisational constraints did not allow sampling
intervals shorter than six months, and this sampling interval
may have been too long for a robust analysis of acquisition
rates and duration of carriage. The relatively small number of
300 study members also led to a rather low sensitivity and
thus to the late detection of the serogroup A ST7 colonisation
in the district. Meningococcal colonisation with minor clones
might also have been undetected.
In industrialised countries, approximately 10% of individ-
uals from the general population are carrying meningococci
at any one time [31]. In children younger than four years,
carriage rates are less than 3%. They increase to 20%–40% in
teenagers and young adults [27,31–33] and decrease again to
less than 10% in older age groups. In contrast, invasive
meningococcal disease is most common in young children
Figure 2. Age and Sex Patterns of Colonisation and Disease
(A) Carriage of meningococci (all serogroups and NG; cumulation of all
surveys) in the different age groups of the male (light grey bars) and
female (dark grey bars) population are shown. 95% CIs are indicated.
These CIs do not allow for repeated sampling.
(B) Carriage of N. lactamica in the different age groups (mean over all
surveys) of the male (light grey bars) and the female population (dark
grey bars) are shown. 95% CIs are indicated. These CIs do not allow for
repeated sampling.
(C) Age spectrum of IR of meningococcal meningitis in the male (circles)
and female (triangles) population of the KND in the epidemic of 1996–
1997 (dark grey) versus the interepidemic period 2001–2005 (light grey).
Denominator is the district population 1995–1999. On the primary y-axis
the epidemic IRs and on the secondary y-axis the interepidemic IRs are
indicated.
doi:10.1371/journal.pmed.0040101.g002
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meningococcal disease in most industrialised countries
ranges from less than one to ﬁve cases per 100,000
population. In industrialised settings, meningococcal strains
collected from patients and carriers differ genetically and
serologically [27]. Typically, the populations of meningococci
carried are highly diverse, with a low representation of the
invasive serogroups A, B, C, Y, and W135 [5,28–30]. The
genetic composition of the strains carried is relatively
constant over time, and up to 50% are serologically
nongroupable [5,31]. Encapsulation is thought to reduce
adherence to pharyngeal epithelial cells, and loss of
expression of capsular polysaccharide may be an adaptation
to long-term carriage [34]. Colonisation with NG strains may
be beneﬁcial to the host by eliciting cross-reactive immune
responses to noncapsular meningococcal surface antigens
[34].
The observed lack of a stable and genetically diverse
resident pharyngeal ﬂora of meningococci in the KND may
explain why incoming new clones can spread so successfully
in populations of the African meningitis belt. The instability
in the resident ﬂora evidently leads to clonal waves of
colonisation typically lasting for about four years and, in the
case of hypervirulent lineages, disease outbreaks or epidem-
ics. We found that the case-to-carrier ratio was generally
much higher for serogroup A than for serogroup X
meningococci, reﬂecting the marked difference in virulence
between these two serogroups. Only in the dry season of 2001
at the beginning of the A ST7 colonisation and disease wave
did we ﬁnd patient isolates that were unrepresented during
the corresponding colonisation survey. The highest A ST7
colonisation rate (4.3% in April 2004) was associated with the
largest meningococcal meningitis outbreak observed during
the entire study period. These data give no strong indication
for a change in the case-to-carrier ratio in the course of the
serogroup A ST7 outbreak.
New contact of the population with genoclouds that have
epidemic potential does not always lead to high colonisation
rates. For example, we recovered isolates resembling those
responsible for the 2002–2004 epidemics in Burkina Faso
from a few carriers in KND in 2004, but we did not observe
any waves of W135 colonisation. Fluctuations of pharyngeal
microﬂora of the population, however, are not conﬁned to
the meningococci. For example, the N. lactamica colonisation
rate also changed in the course of the study. In addition, an
outbreak of pneumococcal meningitis occurred during the
study period with features (seasonality, clonality, and a broad
age spectrum) characteristic of meningococcal epidemics
[24]. Increasing herd immunity may be responsible for the
disappearance of dominating genoclouds. However, changes
in herd immunity do not fully explain the complete
disappearance of the A ST5 genocloud two years after the
1996/1997 epidemic, nor the emergence of the closely related
A ST7 genocloud after only a short time interval.
The age distribution of healthy carriers in the KND with
peak carriage rates in teenagers and young adults was similar
to that found in many European colonisation studies
[5,31,33]. The incidence of meningitis during the disease
outbreaks in the years 1998–2005 was highest in children less
than ten years old, comparable to endemic disease in
industrialised countries. It is thought that immune responses
elicited by colonisation with meningococci and other anti-
genically cross-reactive microorganisms are responsible for
the decreased disease susceptibility in the older age groups.
This difference in age pattern between colonisation and
disease may imply that natural serum antibody-mediated
immunity against invasive disease develops much more
efﬁciently than secretory IgA-mediated protection against
colonisation.
However, during the epidemic in 1996–1997, the age
distribution of meningitis patients resembled that of menin-
gococcal colonisation, consistent with reports of most large
meningococcal epidemics [1,2,35,36]. During the epidemic
the disease susceptibility of the whole population was
increased, and an overall IR of 9.7 per 1,000 was recorded.
The fact that the epidemic incidence of meningitis dramat-
ically exceeded endemic attack rates also in children less than
ten years old, argues against the ‘‘two hit’’ hypothesis, that
susceptibility to disease is associated with blocking serum IgA
elicited by colonisation of the gut with cross-reactive micro-
organisms [37].
The factors that initiate epidemics in the meningitis belt
are incompletely understood. Contact of a population with a
hyperinvasive new genocloud that is antigenically distinct
enough to escape natural immunity may lead to an epidemic.
Loss of natural immunity in exposed individuals over time
and new birth cohorts may make a population increasingly
susceptible. However, epidemics are not always associated
with the appearance of a new clone [1]. This suggests a role of
environmental triggers, such as.periods of hot, dry, and dusty
weather, copathogens, or social factors. Despite intense
annual A/C polysaccharide vaccination campaigns carried
out in the KND since 1998, outbreaks with IRs of up to 80 per
100,000 occurred between 2002 and 2004. Even though, this
incidence was less than one-tenth of the disease burden
during the 1996–1997 epidemic in the KND, it was still several
times higher than in industrialised countries [38]. It is not
clear whether herd immunity elicited by the serogroup A ST5
epidemic, lack of environmental triggers, or the vaccination
campaigns have prevented a large A ST7 epidemic.
Meningococcal vaccines protect individuals from disease by
eliciting bactericidal serum antibodies [39]. Recent studies
following the introduction of conjugate C vaccines in the
United Kingdom have demonstrated that capsule conjugate
vaccines also affect carriage and transmission by inducing
mucosal immune responses [40,41]. Herd immunity may play
a key role in the control of meningococcal infection using
meningococcal conjugate vaccines [42]. An affordable se-
rogroup A conjugate vaccine may soon become available and
introduced in the African meningitis belt (http://www.
meningvax.org). Serogroup replacement and the emergence
of escape variants [43] are potential consequences of limited-
spectrum vaccines, but these factors cannot be well under-
stood without carriage studies. Our data suggest that
successive waves of meningococci replace each other in the
meningitis belt, some leaving little trace in disease surveil-
lance statistics because of their low invasiveness. Once
conjugate vaccines are introduced it will be critical to ensure
that there is no replacement of vaccine serogroups with
invasive alternatives. Carriage studies will play an important
role in monitoring bacterial dynamics in order to anticipate
any such problems and to prepare responses, such as mass
vaccination with a supplementary carbohydrate vaccine.
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Background. Bacterial meningitis is a rare but often fatal infection of the
meninges—the thin membrane around the brain and the spinal cord. It
can be caused by several types of bacteria, but meningococcal
meningitis, which is caused by Neisseria meningitidis, is the most
common form of bacterial meningitis in children and the second most
common form in adults. About 10% of healthy people have N.
meningitidis growing in their nose and throat; the bacteria are spread
by exposure to infected respiratory secretions. In these ‘‘carriers,’’ the
immune system keeps the bug in check but sometimes this surveillance
fails, N. meningitidis enters the bloodstream and travels to the brain,
where it infects the meninges and causes inflammation. The symptoms
of meningococcal meningitis are sudden fever, headache, and a stiff
neck and, even if strong antibiotics are given quickly, 10%–15% of
patients die.
Why Was This Study Done? Outbreaks of meningococcal meningitis
occur all over the world, but the highest burden of disease is in the
African meningitis belt, which stretches across sub-Saharan Africa from
Senegal to Ethiopia. Here, localized epidemics of meningococcal
meningitis occur every eight to 12 years during the dry season. Control
of these epidemics relies on their early detection followed by mass
immunization. This approach can be hard to implement in countries with
limited resources, but the introduction of other control measures (for
example, routine childhood immunization) requires an understanding of
how the spread of different strains of N. meningitides through the
community causes periodic epidemics. In this study, the researchers have
studied the long-term dynamics of colonization by N. meningitidis and
the occurrence of meningococcal meningitis in one region of the African
meningitis belt.
What Did the Researchers Do and Find? The researchers took throat
swabs twice a year from people living in rural northern Ghana for eight
years. They tested each swab for N. meningitidis and determined the
serogroup of the bacteria they found. Bacterial serogroups differ only in
terms of the antigens (molecules recognized by the immune system) that
they express; N. meningitidis is classified into 13 serogroups based on the
sugars that coat its surface. The researchers also used DNA sequencing
to group the bacterial isolates into genoclouds—genetically closely
related groups of meningococci represented by a sequence type (ST)
number. Finally, they monitored meningococcal disease throughout the
study and determined the serogroup and genocloud of patient isolates.
Their results show colonization of 6% of the study population by N.
meningitidis and reveal three consecutive waves of colonization and
disease characterized by the presence of a serogroup A ST5 genocloud, a
serogroup X ST751 genocloud, and finally a serogroup A ST7 genocloud.
Colonizing bacteria isolated in this study in Ghana, the researchers
report, changed their genotype more frequently but were less
genetically diverse than those isolated in industrialized countries. In
addition, the commonest serogroups of N. meningitidis in carriers in
Ghana were disease-causing serogroups, whereas in industrialized
countries these serogroups are rarely seen in carriers. However, non-
groupable bacteria (bacteria that lack surface sugars), although common
in industrialized countries, were rare in Ghana.
What Do These Findings Mean? These findings begin to explain why
epidemics of meningococcal meningitis are common in the African
meningitis belt. Because there isn’t a stable, genetically diverse
population of N. meningitidis in carriers, the immune systems of people
living here may not be optimally prepared to deal with new bacterial
clones that arrive in the region, and this lack of immunity could result in
frequent epidemics. However, because the researchers took relatively
few samples every six months from one small area of the meningitis belt,
the genetic diversity of N. meningitidis over the whole region might be
considerably greater than that colonizing the study population. Never-
theless, the description of successive waves of meningococci coloniza-
tion in Ghana has important implications for the proposed introduction
of childhood vaccination against meninogococcal disease in the African
meningitis belt. If this vaccination program goes ahead, warn the
researchers, it will be essential to monitor which strains of N. meningitidis
are colonizing the population and to have emergency plans ready to
deal with any emerging disease-causing serogroups that are not covered
by the vaccine.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040101.
  The Web sites of the institutions at which this research was performed,
the Swiss Tropical Institute and the Navrongo Health Research Centre,
provide more information about the programs
  The World Health Organization provides information on meningococ-
cal disease, including the African meningitis belt (in English, Spanish,
Chinese, Russian, and Arabic)
  Information on meningitis and vaccines and their potential use in
Africa is available from the Meningitis Vaccine Project (in English and
French)
  Medline Plus has encyclopedia pages on meningococcal meningitis
  The US Centers for Disease Control and Prevention provides
information on meningococcal disease (in English and Spanish)
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